H. Pylori Infection and Metabolic Syndrome: A Retrospective Cross-Sectional Study
Association Between Helicobacter Pylori Infection and Metabolic Syndrome: A Retrospective Cross-Sectional Study
1 other identifier
observational
5,218
1 country
1
Brief Summary
This retrospective cross-sectional study evaluates the association between Helicobacter pylori infection and metabolic syndrome using health examination data from 5,218 adults at Nanjing First Hospital. Participants are divided into H. pylori-positive and negative groups based on urea breath test results. The primary outcome is metabolic syndrome prevalence (CDS 2020 criteria). Multivariable logistic regression will be used to assess the independent association, with subgroup analyses by age and sex.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
June 11, 2026
CompletedFirst Posted
Study publicly available on registry
June 16, 2026
CompletedJune 16, 2026
April 1, 2026
1 year
June 11, 2026
June 11, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of Metabolic Syndrome
Metabolic syndrome is defined according to the Chinese Diabetes Society (CDS) 2020 criteria. Participants meeting three or more of the following five criteria are classified as having metabolic syndrome: (1) central obesity: waist circumference ≥90 cm in males or ≥85 cm in females; (2) hyperglycemia: fasting blood glucose ≥6.1 mmol/L or previously diagnosed diabetes on treatment; (3) hypertension: blood pressure ≥130/85 mmHg or previously diagnosed hypertension on treatment; (4) hypertriglyceridemia: fasting triglycerides ≥1.70 mmol/L; (5) low HDL-cholesterol: fasting HDL-cholesterol \<1.04 mmol/L.
Baseline
Study Arms (2)
H. pylori Positive Group
Participants with positive 13C or 14C urea breath test result
H. pylori Negative Group
Participants with negative 13C or 14C urea breath test result
Interventions
No intervention. This is an observational study.
Eligibility Criteria
Adults (≥18 years) who completed annual health examinations at Nanjing First Hospital between May 1, 2024 and May 1, 2025, with complete data on H. pylori breath testing and metabolic syndrome components (waist circumference, blood pressure, fasting glucose, triglycerides, HDL-cholesterol). Pregnant/lactating women and those with severe organ dysfunction or malignancy were excluded.
You may qualify if:
- Age ≥18 years
- Completed annual health examination at Nanjing First Hospital Health Management Center between May 1, 2024 and May 1, 2025
- Underwent 13C or 14C urea breath test for H. pylori status assessment
- Complete data on the following measurements: height, weight, waist circumference, systolic blood pressure, diastolic blood pressure, fasting blood glucose, triglycerides, and high-density lipoprotein cholesterol
- No missing data on key study variables
You may not qualify if:
- Missing key data on H. pylori test results (13C or 14C urea breath test)
- Missing any of the following primary metabolic indicators: waist circumference, blood pressure (systolic/diastolic), fasting blood glucose, triglycerides, or HDL-cholesterol
- Pregnancy or lactation
- History of severe liver dysfunction
- History of severe kidney dysfunction
- History of malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanjing First Hospital, Nanjing Medical University
Nanjing, Jiangsu, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2026
First Posted
June 16, 2026
Study Start
May 1, 2024
Primary Completion
May 1, 2025
Study Completion
March 1, 2026
Last Updated
June 16, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share